Trial
NCT02532010
Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Weill Medical College of Cornell University
Collaborators
—
Condition
Acute Myeloid Leukemia (AML)
Intervention
Pacritinib
Why stopped
The study was put on clinical hold by the sponsor since Feb 9th 2016, and was later decided not to re-open due to financial constraints.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-06-15